India’s billionaire landscape has witnessed a major shakeup this year. The M3M Hurun India Rich List 2026, released on September 23, reveals that Gautam Adani has reclaimed the title of the richest Indian, overtaking Mukesh Ambani after a dramatic swing in fortunes. Here’s the complete top 10 breakdown.

Richest Indian 2026: Top 10 Wealthiest People According to Hurun India Rich List

1. Gautam Adani – ₹9.23 Lakh Crore

Adani and family have reclaimed the No. 1 spot, with wealth rising 13% year-on-year, driven largely by strength across the group’s energy, ports, and infrastructure businesses.

2. Mukesh Ambani – ₹8.63 Lakh Crore

Reliance Industries chairman Ambani slips to second place after his wealth declined by 10%, ending his brief reign atop last year’s list.

3. Lakshmi Niwas Mittal – ₹3.39 Lakh Crore

The London-based ArcelorMittal magnate jumped an impressive eight places this year, with his wealth surging 93% amid firmer European steel prices and trade protection measures.

4. Cyrus S. Poonawalla – ₹3.03 Lakh Crore

The Serum Institute of India chief continues to hold a strong position, backed by the pharmaceutical giant’s global vaccine manufacturing dominance.

5. Roshni Nadar Malhotra – ₹2.79 Lakh Crore

HCL Technologies chairperson remains India’s richest woman, continuing her strong presence in the top five.

6. Kumar Mangalam Birla – ₹2.69 Lakh Crore

The Aditya Birla Group chairman holds steady in the top tier, anchored by diversified holdings across cement, metals, and telecom.

7. Dilip Shanghvi – ₹2.65 Lakh Crore

Sun Pharmaceutical Industries’ founder remains one of India’s most consistent pharma billionaires.

8. Azim Premji – ₹2.63 Lakh Crore

The Wipro founder and philanthropist continues to feature prominently among India’s tech wealth creators.

9. Anil Agarwal – ₹2.08 Lakh Crore

Vedanta Group’s chairman rounds out the top nine, reflecting strength in mining and natural resources.

10. Samir Mehta – ₹1.89 Lakh Crore

Torrent Pharmaceuticals’ chairman completes the list, representing continued growth in India’s pharma sector.